New Blood Proteins Linked to Parkinson's Progression
Researchers identified six proteins that could help track how Parkinson's disease progresses in patients over time.
Updated on Oct. 30, 2026 in Alzheimer’s
Live Poll
Do you believe long-term health tracking helps manage chronic disease progression effectively?
Researchers have identified six specific blood proteins linked to the progression of Parkinson's disease. These findings, derived from an analysis of 166 patients, may eventually help clinicians better predict how the condition evolves over time.
Why it matters
Single baseline biomarkers have historically struggled to predict how Parkinson's progresses, making it difficult to tailor long-term treatment strategies. This research provides a more detailed, longitudinal look at how specific proteins correlate with clinical worsening.
In a study using the PROMOVE registry, researchers analyzed 166 patients through longitudinal serum proteomics covering 297 proteins. They identified six proteins tied to clinical progression, though these findings are not yet a validated diagnostic tool.
The players
PROMOVE registry
A clinical database used to track longitudinal patient data for Parkinson's disease research.
The details
Researchers utilized linear mixed-effects models to isolate how protein levels change within individuals over time compared to between-subject differences. They assessed repeated OFF-state clinical exams to track motor and cognitive status. Higher levels of DDC were linked to increased levodopa needs, while CD276 and POSTN were associated with worsened daily living scores. Additionally, elevated VEGF-C and IL19 correlated with worse motor scores, and higher IL12 levels were tied to lower cognitive scores.
Timeline
October 30, 2026: The research findings were published.
Health Landscape
Parkinson's research is shifting from relying on single baseline snapshots to monitoring longitudinal proteomic changes. This development builds upon the ongoing work of the PROMOVE registry to better define disease trajectories.
These findings are currently limited to research settings and do not change how you should manage your medications today. If you are tracking Parkinson's progression, these results are worth discussing with your neurologist to understand what new monitoring tools may be on the horizon.
The takeaway
The study suggests that monitoring specific protein levels over time could offer a clearer window into how Parkinson's disease evolves. Continue tracking your daily symptoms and discuss any concerns about disease progression with your physician at your next scheduled appointment.
Further reading
For more information on the latest research in the field, visit Alzheimer’s.
More information
View the peer-reviewed research article for complete study data.
Source note: This article includes information reported by Nature.
Live Poll
Do you believe long-term health tracking helps manage chronic disease progression effectively?
